Breaking News Instant updates and real-time market news.

NRG

NRG Energy

$24.39

0.06 (0.25%)

, NEE

NextEra Energy

$147.72

0.48 (0.33%)

16:28
08/10/17
08/10
16:28
08/10/17
16:28

NRG Energy looking to sell as much as $4B in assets, Bloomberg says

NextEra Energy (NEE) and Global Infrastructure Partners are among at least seven suitors exploring buying renewable energy assets from NRG Energy (NRG), Bloomberg reports. Blackstone (BX), Borealis Infrastructure Management, John Hancock Life, and KKR (KKR) are also weighing making offers, the report says, citing people familiar with the matter. An actual deal may still be months away, the report says. NRG is seeking to divest as much as $4B worth of assets, including its interest in solar and wind farm owner NRG Yield Inc., the report notes. Reference Link

NRG

NRG Energy

$24.39

0.06 (0.25%)

NEE

NextEra Energy

$147.72

0.48 (0.33%)

BX

Blackstone

$32.30

-1.1 (-3.29%)

KKR

KKR

$18.50

-0.62 (-3.24%)

NRG NRG Energy
$24.39

0.06 (0.25%)

07/13/17
LEHM
07/13/17
NO CHANGE
Target $27
LEHM
Overweight
NRG Energy price target raised to $27 from $20 at Barclays
Barclays analyst Daniel Ford raised his price target for NRG Energy to $27 saying the company's transformation plan is "significantly accretive." NRG's plan to sell between a 50%-100% stake in NRG Yield and Renewables, plus 6GWs of conventional generation can achieve management's projected $2.0B-$4.5B in cash proceeds and reduction of $8.7B in debt, Ford tells investors in a research note. His upside case has $11 per share of valuation accretion to $38 per share. The analyst reiterates an Overweight rating on the shares.
05/11/17
DBAB
05/11/17
NO CHANGE
Target $14
DBAB
Buy
Calpine unlikely to go private above $16 per share, says Deutsche Bank
Deutsche Bank analyst Abe Azar sees few strategic acquirers for Calpine (CPN), making going private or remaining public the most likely outcomes in his view. The Wall Street Journal reported yesterday that the company is exploring a sale. Market power issues in Texas make a combination with Vistra Energy (VST) or NRG Energy (NRG) unlikely, and while PSEG (PEG) and Exelon (EXC) could afford buying Calpine, such a deal would be a shift in strategy for both. The analyst finds it unlikely that a go-private deal gets done much north of $16 per share. He believes, however, that a mid-teens per share takeout is possible "with some creative structuring." Even without a deal, Calpine offers value based on its cash flow profile, Azar contends. The analyst reiterates a Buy rating on Calpine with a $14 price target.
06/01/17
UBSW
06/01/17
UPGRADE
Target $20
UBSW
Buy
NRG Energy upgraded to Buy from Neutral at UBS
UBS analyst Julien Dumoulin-Smith upgraded NRG Energy to Buy and raised his price target for the shares to $20 from $19. The proposed GenOn settlement is a positive and, along with the latest PJM auction, adds "clarity to the story," Dumoulin-Smith tell investors in a research note. He also views the NRG's cost cutting initiative as the major near-term catalyst for the shares.
05/24/17
FBCO
05/24/17
NO CHANGE
FBCO
Outperform
Exelon a net winner despite 'disappointing' 2020/21 auction, says Credit Suisse
Following PJM Interconnection's annual capacity auction, Credit Suisse analyst Michael Weinstein called Exelon a net winner despite "disappointing" RPM results for the 2020/21 capacity auction. The results for the EMAAC area should help drive a net positive result for Exelon assuming the same amount of capacity cleared year-over-year, he indicated. PSEG (PEG) and Calpine (CPN)are also "net beneficiaries," while Dynegy (DYN), NRG Energy (NRG) and FirstEnergy (FE) will "bear the brunt of a poor RTO showing," Weinstein tells investors.
NEE NextEra Energy
$147.72

0.48 (0.33%)

09/23/16
09/23/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Underperform from Sector Perform by RBC analyst Mark Mahaney, who cut his price target to $14 from $17. The research firm's survey of more than 1,100 advertising professionals and their attitudes towards Facebook (FB), Google (GOOG), Twitter and other high-profile names showed that, despite marketing budgets continuing to shift online, interest in the microblog platform appears to be declining. Of note, Twitter shares have surged this morning after CNBC's David Faber reported that Twitter is moving closer to selling itself and has received expressions of interest in a possible sale, although no deal is imminent. 2. Yum! Brands (YUM) downgraded to Outperform from Top Pick by RBC Capital analyst David Palmer based on valuation. His price target on Yum shares remains $97. 3. Becton Dickinson (BDX) downgraded to Sell from Neutral by Citi analyst Amit Hazan, who thinks a cyclical U.S. slowdown will push the company's organic growth below expectations. The analyst, who also sees a diminishing impact on Becton's growth from emerging markets, cut his price target for the shares to $165 from $167. 4. NextEra Energy (NEE) downgraded to Hold from Buy by Deutsche Bank analyst Jonathan Arnold, as he sees limited near-term upside with the shares up 23% year-to-date. "Extraordinarily frosty commentary" from two of three PUCT commissioners yesterday regarding NextEra's Oncor deal indicates an uphill battle in getting it approved, Arnold tells investors. 5. AVANGRID (AGR) downgraded to Underweight from Neutral by JPMorgan analyst Christopher Turnure, who thinks both the company's growth guidance and consensus expectations "appear ambitious." He lowered his price target for the shares to $41 and $44 and notes he does not have confidence in AVANGRID's near-term growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/16
BOFA
09/27/16
NO CHANGE
BOFA
NextEra Energy added to US 1 List, Jack in the Box removed at BofA/Merrill
01/30/17
DBAB
01/30/17
UPGRADE
Target $33
DBAB
Buy
NextEra Energy Partners upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Jonathan Arnold upgraded NextEra Energy Partners (NEP) to Buy citing valuation and "supportive actions" from parent NextEra Energy (NEE). The analyst raised his price target for the shares to $33 from $29.
07/24/17
GSCO
07/24/17
INITIATION
Target $160
GSCO
Buy
NextEra Energy reinstated with a Buy at Goldman Sachs
Goldman analyst Michael Lapides reinstated NextEra Energy with a Buy and a $160 price target.
BX Blackstone
$32.30

-1.1 (-3.29%)

05/22/17
05/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Neutral at JPMorgan with analyst Rod Hall saying while more negative news from the Apple (AAPL) royalty suit is likely, "material fundamental upside" exists from the closure of the NXP Semiconductors (NXPI) by the end of this year. The analyst views the deal as highly accretive. Hall also believes Apple ultimately will want to preserve its commercial relationship with Qualcomm. 2. Motorola Solutions (MSI) upgraded to Outperform from Market Perform at Raymond James with analyst Tavis McCourt saying shares look increasingly attractive based on improved demand visibility that is less economically sensitive than many of its peers, and demand catalysts from FirstNet buildouts that are expected to start in 2018. 3. Entegris (ENTG) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Toshiya Hari citing the recent pullback in shares and maintained a $29 price target. 4. Blackstone (BX) upgraded to Buy from Neutral at Citi with analyst William Katz saying the company's intentions to raise a $40B infrastructure fund should be a "valuation catalyst." 5. Cree (CREE) upgraded to Outperform from Market Perform at JMP Securities with analyst Joseph Osha saying he thinks that the company's new CEO could make positive changes at the company. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/17
SBSH
05/22/17
UPGRADE
Target $40
SBSH
Buy
Blackstone upgraded to Buy from Neutral at Citi
Citi analyst William Katz upgraded Blackstone Group to Buy and raised his price target for the shares to $40 from $32. The company's intentions to raise a $40B infrastructure fund should be a "valuation catalyst," the analyst contends.
04/10/17
MSCO
04/10/17
NO CHANGE
Target $36
MSCO
Overweight
Morgan Stanley says to own Blackstone into the Q1 print
Morgan Stanley analyst Michael Cyprys says to buy Blackstone into the Q1 print saying its a best-in-class franchise which saw a number of large transactions close and has unparalleled fundraising ability. Cyprys rates Blackstone an Overweight with a $36 price target.
05/22/17
JMPS
05/22/17
NO CHANGE
JMPS
Blackstone deal with Saudi Arabia positive, says JMP Securities
JMP Securities analyst Devin Ryan says that the new infrastructure investment vehicle that Blackstone launched with the Public Investment Fund of Saudi Arabia may boost the shareholder value of Blackstone by over 10%. The analyst adds that the deal shows that Blackstone "can evolve and innovate," which makes its growth outlook "strong." He keeps a $38 price target and Outperform rating on the shares.
KKR KKR
$18.50

-0.62 (-3.24%)

07/25/17
LEER
07/25/17
DOWNGRADE
Target $66.5
LEER
Market Perform
WebMD downgraded to Market Perform from Outperform at Leerink
Leerink analyst David Larsen downgraded WebMD (WBMD) to Market Perform from Outperform after the company announced that it has entered into a definitive agreement to be acquired by Internet Brands, a KKR (KKR) portfolio company, in a transaction valued at about $2.8B. The analyst also raised his price target on WebMD's shares to $66.50 from $60.
08/09/17
BARD
08/09/17
NO CHANGE
BARD
Neutral
AmerisourceBergen settlement ups odds of PharMerica switch, says Baird
Baird analyst Eric Coldwell said AmerisourceBergen's (ABC) 10-Q last week showed that the company and PharMerica (PMC) have tentatively agreed to settle their long-running legal fight, which he reads as significantly increasing the odds of AmerisourceBergen displacing incumbent Cardinal Health (CAH) after KKR (KKR) and minority investor Walgreens (WBA) complete their deal to buy PharMerica. Coldwell has a Neutral rating and $89 price target on AmerisourceBergen shares.
05/09/17
NEED
05/09/17
NO CHANGE
Target $16
NEED
Buy
KKR adds $5 per share to Pandora value, says Needham
Noting that Pandora (P) announced it had raised $150M by selling a 5-year, 8% convertible preferred security to KKR (KKR), Needham analyst Laura Martin calculates that adding KKR to the Pandora story adds $5 per share to the latter's value, implying that it should trade up to $15 per share on the news over time. The analyst believes KKR provides a financial safety net, and expects KKR's exit time frame to be 5 years, giving public shareholders a clearer exit path. She reiterates a Buy rating and $16 price target on Pandora's shares.
05/09/17
PIPR
05/09/17
NO CHANGE
Target $18
PIPR
Overweight
Pandora sale path accelerated with KKR investment, says Piper Jaffray
Piper Jaffray analyst Stan Meyers believes Pandora's (P) path towards a potential sale has accelerated following KKR's (KKR) strategic investment. The analyst also expects Pandora's margins in its core radio business to continue improving. He remains "upbeat" on the shares with an Overweight rating and $18 price target.

TODAY'S FREE FLY STORIES

BKD

Brookdale Senior Living

$10.42

0.11 (1.07%)

08:52
11/20/17
11/20
08:52
11/20/17
08:52
Recommendations
Brookdale Senior Living analyst commentary  »

Brookdale Senior Living…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
11/20/17
11/20
08:50
11/20/17
08:50
General news
U.S. equities are trading moderately firmer »

U.S. equities are trading…

ACOR

Acorda Therapeutics

$17.80

0.55 (3.19%)

08:49
11/20/17
11/20
08:49
11/20/17
08:49
Technical Analysis
Technical View: Acorda Therapeutics down on end of tozadenant development »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

KO

Coca-Cola

$45.71

-0.84 (-1.80%)

08:46
11/20/17
11/20
08:46
11/20/17
08:46
Recommendations
Coca-Cola analyst commentary  »

Coca-Cola investor day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$40.82

8.97 (28.16%)

08:45
11/20/17
11/20
08:45
11/20/17
08:45
Recommendations
Foot Locker analyst commentary  »

Foot Locker price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:45
11/20/17
11/20
08:45
11/20/17
08:45
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

JNJ

Johnson & Johnson

$138.00

-0.87 (-0.63%)

08:43
11/20/17
11/20
08:43
11/20/17
08:43
Hot Stocks
EU extends license for Janssen's Zytiga plus prednisone »

Janssen-Cilag…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

LIVN

LivaNova

$84.32

0.04 (0.05%)

08:42
11/20/17
11/20
08:42
11/20/17
08:42
Recommendations
LivaNova analyst commentary  »

LivaNova received fair…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 01

    Dec

MNST

Monster Beverage

$62.17

0.17 (0.27%)

, KO

Coca-Cola

$45.71

-0.84 (-1.80%)

08:40
11/20/17
11/20
08:40
11/20/17
08:40
Downgrade
Monster Beverage, Coca-Cola rating change  »

Monster Beverage…

MNST

Monster Beverage

$62.17

0.17 (0.27%)

KO

Coca-Cola

$45.71

-0.84 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NQ

NQ Mobile

$4.05

-0.05 (-1.22%)

08:40
11/20/17
11/20
08:40
11/20/17
08:40
Hot Stocks
NQ Mobile provides update on FL Mobile Divestment »

NQ Mobile provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENSG

Ensign Group

$23.77

0.22 (0.93%)

08:38
11/20/17
11/20
08:38
11/20/17
08:38
Recommendations
Ensign Group analyst commentary  »

Ensign Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$20.29

0.03 (0.15%)

, CAVM

Cavium

$75.83

-0.47 (-0.62%)

08:37
11/20/17
11/20
08:37
11/20/17
08:37
Hot Stocks
Marvell: Cavium deal doesn't include divestitures, changes to Cavium's portfolio »

On the conference call…

MRVL

Marvell

$20.29

0.03 (0.15%)

CAVM

Cavium

$75.83

-0.47 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

BKS

Barnes & Noble

$7.45

0.35 (4.93%)

08:35
11/20/17
11/20
08:35
11/20/17
08:35
Hot Stocks
Barnes & Noble announces Black Friday weekend deals »

Barnes & Noble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

ARAY

Accuray

$4.80

-0.1 (-2.04%)

08:35
11/20/17
11/20
08:35
11/20/17
08:35
Technical Analysis
Technical View: Accuray rallies in pre-market »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNUS

Genius Brands

$2.88

0.02 (0.70%)

08:34
11/20/17
11/20
08:34
11/20/17
08:34
Hot Stocks
Genius Brands signs multiple content sales deals for children's programming »

Genius Brands expands the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$34.95

-0.33 (-0.94%)

08:34
11/20/17
11/20
08:34
11/20/17
08:34
Initiation
Aimmune initiated  »

Aimmune initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

WOR

Worthington

$40.24

0.03 (0.07%)

08:33
11/20/17
11/20
08:33
11/20/17
08:33
Hot Stocks
WAVE to sell EMEA, Pacific Rim units »

Worthington (WOR)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIV

On Track Innovations

$1.13

-0.01 (-0.88%)

08:32
11/20/17
11/20
08:32
11/20/17
08:32
Hot Stocks
On Track Innovations: UNO 6 selected by CityEV as cashless payment solution »

On Track Innovations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

MDSO

Medidata

$68.64

-0.85 (-1.22%)

08:32
11/20/17
11/20
08:32
11/20/17
08:32
Hot Stocks
Medidata, MEL MEDICAL announce multi-year Medidata eTMF agreement »

Medidata announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PNTR

Pointer Telocation

$17.55

-0.2 (-1.13%)

08:30
11/20/17
11/20
08:30
11/20/17
08:30
Downgrade
Pointer Telocation rating change  »

Pointer Telocation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZH

Beazer Homes

$20.50

0.04 (0.20%)

08:29
11/20/17
11/20
08:29
11/20/17
08:29
Recommendations
Beazer Homes analyst commentary  »

Beazer Homes price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:28
11/20/17
11/20
08:28
11/20/17
08:28
Conference/Events
The Board of Governors of the Federal Reserve System holds a closed meeting »

The Board of Governors of…

DG

Dollar General

$85.50

0.59 (0.69%)

, DLTR

Dollar Tree

$94.61

-0.02 (-0.02%)

08:28
11/20/17
11/20
08:28
11/20/17
08:28
Recommendations
Dollar General, Dollar Tree analyst commentary  »

Dollar General price…

DG

Dollar General

$85.50

0.59 (0.69%)

DLTR

Dollar Tree

$94.61

-0.02 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

OMI

Owens & Minor

$19.14

0.23 (1.22%)

08:27
11/20/17
11/20
08:27
11/20/17
08:27
Recommendations
Owens & Minor analyst commentary  »

Owens & Minor price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIZZ

National Beverage

$102.23

0.32 (0.31%)

08:26
11/20/17
11/20
08:26
11/20/17
08:26
Upgrade
National Beverage rating change  »

National Beverage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.